Mustafa Kemal Erol1, Meral Kayıkçıoğlu2, Mustafa Kılıçkap3. 1. Department of Cardiology, Şişli International Kolan Hospital; İstanbul-Turkey. 2. Department of Cardiology, Faculty of Medicine, Ege University; İzmir-Turkey. 3. Department of Cardiology, Faculty of Medicine, Ankara University; Ankara-Turkey.
Abstract
OBJECTIVE: To the best of our knowledge, there is no up-to-date information regarding the presentation, management, and clinical course of patients with acute myocardial infarction (MI) in Turkey. The TURKMI registry is designed to provide an insight into the characteristics, management from the symptoms onset to the hospital discharge, and outcome of patients with acute MI in Turkey. METHODS: The TURKMI study, as a nationwide registry, will be conducted in 50 percutaneous coronary intervention-capable centers, selected from each EuroStat NUTS region in Turkey according to their population sampling weight, prioritizing the hospital volume in each region. All consecutive patients with acute MI admitted to the coronary care units within the 48 hours of the symptoms onset will be prospectively enrolled during a predefined 2-week period. The first step of the study has a cross-sectional design in which baseline information such as symptoms, risk factors, time periods at each step from the symptoms onset to revascularization, way of arrival to hospital, biochemical analysis, and in-hospital management and outcome will be assessed. The second step has a cohort characteristic in which the enrolled patients will be followed-up up to 2 years. Follow-up visits will be conducted at the 1st, 6th, 12th, and 24th month, and predictors and risk of cardiovascular events and implementation of guidelines will be assessed as secondary outcomes. CONCLUSION: The national TURKMI registry is expected to provide important information to improve the national policy regarding diagnosing, management, and outcomes of MI in Turkey.
OBJECTIVE: To the best of our knowledge, there is no up-to-date information regarding the presentation, management, and clinical course of patients with acute myocardial infarction (MI) in Turkey. The TURKMI registry is designed to provide an insight into the characteristics, management from the symptoms onset to the hospital discharge, and outcome of patients with acute MI in Turkey. METHODS: The TURKMI study, as a nationwide registry, will be conducted in 50 percutaneous coronary intervention-capable centers, selected from each EuroStat NUTS region in Turkey according to their population sampling weight, prioritizing the hospital volume in each region. All consecutive patients with acute MI admitted to the coronary care units within the 48 hours of the symptoms onset will be prospectively enrolled during a predefined 2-week period. The first step of the study has a cross-sectional design in which baseline information such as symptoms, risk factors, time periods at each step from the symptoms onset to revascularization, way of arrival to hospital, biochemical analysis, and in-hospital management and outcome will be assessed. The second step has a cohort characteristic in which the enrolled patients will be followed-up up to 2 years. Follow-up visits will be conducted at the 1st, 6th, 12th, and 24th month, and predictors and risk of cardiovascular events and implementation of guidelines will be assessed as secondary outcomes. CONCLUSION: The national TURKMI registry is expected to provide important information to improve the national policy regarding diagnosing, management, and outcomes of MI in Turkey.
Authors: Mustafa Kemal Erol; Meral Kayıkçıoğlu; Mustafa Kılıçkap; Arda Güler; Önder Öztürk; Burcu Tuncay; Sinan İnci; İsmail Balaban; Fatih Tatar; Ömer Faruk Çırakoğlu; Emine Gazi; Eftal Murat Bakırcı; Çağrı Yayla; Mehmet Ali Astarcıoğlu; Bilge Duran Karaduman; Ekrem Aksu; Yakup Alsancak; Nadir Emlek; Mustafa Kürşat Tigen; Nihan Turhan Cağlar; Ramazan Düz; Mehmet Inanir; Öner Özdoğan; Oğuz Yavuzgil Journal: Anatol J Cardiol Date: 2021-05 Impact factor: 1.596
Authors: Mustafa Kemal Erol; Meral Kayıkçıoğlu; Mustafa Kılıçkap; Can Baba Arın; Ibrahim Halil Kurt; Ibrahim Aktaş; Yılmaz Güneş; Eyüp Özkan; Taner Şen; Orhan Ince; Ender Örnek; Ramazan Asoğlu; Nesim Aladağ; Utku Zeybey; Ümit Yaşar Sinan; Muhammet Dural; Haşim Tüner; Arda Doğan; Mustafa Yenerçağ; Mehmet Akboğa; Onur Sinan Deveci; Mustafa Umut Somuncu Journal: Anatol J Cardiol Date: 2020-07 Impact factor: 1.596
Authors: Öner Özdoğan; Meral Kayıkçıoğlu; Mustafa Kılıçkap; Cenk Ekmekçi; Murat Küçükukur; Ahmet Arif Yalçın; Mustafa Kemal Erol Journal: Anatol J Cardiol Date: 2022-04 Impact factor: 1.475
Authors: Mustafa Kemal Erol; Meral Kayıkçıoğlu; Mustafa Kılıçkap; Arda Güler; Abdullah Yıldırım; Fatih Kahraman; Veysi Can; Sinan Inci; Sadettin Selçuk Baysal; Okan Er; Utku Zeybey; Çağrı Kafkas; Çağrı Yayla; Can Baba Arin; Ibrahim Aktaş; Ahmet Arif Yalçın; Ömer Genç Journal: Anatol J Cardiol Date: 2020-11 Impact factor: 1.596